Treatment trial for inflammation in and ME, FMS and CFS. We are enrolling patients for a treatment trial using a new nonsteroid anti-inflammatory drug. This drug reduces the C-reactive protein which is an indicator of inflammation. For further information, Please contact me and the ME CFS center at 212 794 2000 for further details. Patient should have a prior elevated C-reactive protein test.
the OTC drug is a new non steroid anti-inflamatory, we have been given a grant to investigate the drug. The Drug will be dispensed FREE
the OTC drug is a new non steroid anti-inflamatory, we have been given a grant to investigate the drug. The Drug will be dispensed FREE